
P. R. Womble
@wombling_gu
MUSC | Ralph H Johnson VA | Urological Oncologist | Health Services Research | Views Mine | RT≠E
ID: 2775797933
19-09-2014 13:22:31
605 Tweet
630 Followers
361 Following

Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplin… pubmed.ncbi.nlm.nih.gov/38771067/ Our fearless leader: kym watt All GU-related darts should be thrown at Talal M Al-Qaoud, Piyush Kumar Agarwal, and moi

1/6: Congrats to our #team on the recent JCO Precision Oncology publication! We've developed a novel 15-gene prognostic signature (15G) for clear cell renal cell carcinoma (ccRCC) to facilitate risk stratification and management. #KidneyCancer #OncologyResearch


ICYMI: This paper from Jane K Nguyen MD PhD and Jesse McKenney on rethinking Gleason grading is a really big deal. Splitting all patterns into "favorable" and "unfavorable" amounts to the best biomarker I think I've ever seen for #prostatecancer.



Chief of urological oncology Todd 〽️ Morgan, MD recently went on the BackTable Urology podcast to talk about germline testing for #prostatecancer patients. 👂🔗 michmed.org/Z7yQN



Tremendous RCT from MUSIC Urology lead by Todd 〽️ Morgan, MD and Dr. Michael Cher assessing decision for adjuvant treatment based on information provided post-prostatectomy (CAPRA-S + genomics or CAPRA-S alone). 🔥 👏🏼 〽️

Data suggesting more people with PrCa (current or treated) should be getting timely organ transplants. Zero evidence (to my knowledge) immunosuppression alters natural history of PrCa. Tanya Watts Kristof Aaron Dahmen Todd 〽️ Morgan, MD bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…


JMT out front for decades 🤩🤩🤩 cc The Johns Hopkins Brady Urological Institute NM Urology


Pleasure to have Dr Michael Rothberg Michael Rothberg, MD Duke Urology here at MUSC Hollings Cancer Center MUSC Health to give us an overview on focal therapy for prostate cancer.


Matvey Tsivian Michael Rothberg, MD Duke Urology MUSC Hollings Cancer Center MUSC Health Great to have the discussion of role of focal therapy in prostate cancer management. To new horizons. Thanks for making the trip. MUSC Urology Residency MUSC Hollings Cancer Center


🎯🎯🎯 work from 🤩 U-M Rogel Cancer Center team showing impact of patient-centered path reports in context of new prostate cancer diagnosis Practical, actionable work channeling goals of National Academy of Medicine #DiagnosticExcellence initiative jamanetwork.com/journals/jama/…


📢🚨 Hot off the press The Lancet Oncology for #kidneycancer! shorturl.at/kAGVd. SABR vs thermal ablation; - Despite ⏫age, ⏬worse GFR, and ⏫tumours for SABR - SABR ⬆️effective than TA (at 1, 2 and 5 yrs) - esp for RCC >4cm - same renal decline (p=0.75) - similar F/U #radonc




What is the evidence for resection in metastatic RCC? Read our mini-review in Eur Urol Focus TLDR; see Figure 1- below. sciencedirect.com/science/articl… Udit Singhal, MD Simpa Salami Todd 〽️ Morgan, MD Ulka Vaishampayan


Congrats to our very own rockstar Gabi Yankelevich, DO on her urology oncology fellowship match at Moffitt Cancer Center and also winning the MUSC Urology Residency resident research award for 2025. MUSC Health